• 1. An artificial photosynthesis system comprising a covalent triazine framework as an electron relay facilitator for photochemical carbon dioxide reduction?
  Siquan Zhang,Shengyao Wang,Liping Guo,Hao Chen,Bien Tan,Shangbin Jin J. Mater. Chem. C, 2020,8, 192-200
• 2. An integrated microfluidic 3D tumor system for parallel and high-throughput chemotherapy evaluation?
  Dan Liu,Rui Hu,Zhongchao Huang,Meilin Sun,Kai Han Analyst, 2020,145, 6447-6455
• 3. Acenaphthenic hopanoids, a novel series of aromatised
  Teresita Carrillo-Hernández,Philippe Schaeffer,Pierre Albrecht Chem. Commun., 2001, 1976-1977
• 4. An integrated digital microfluidic chip for multiplexed proteomic sample preparation and analysis by MALDI-MS?
  Hyejin Moon,Aaron R. Wheeler,Robin L. Garrell,Chang-Jin “CJ” Kim Lab Chip, 2006,6, 1213-1219
• 5. An apparatus for testing water by measurement of its electrical conductivity
  Analyst, 1912,37, 538-543

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Trifluoromethylbenzenes
• Solvents and Organic Chemicals Organic Compounds cyanides/Cyanides

Professional Introduction to 2-Methyl-5-(trifluoromethyl)benzonitrile (CAS No: 261952-03-8)

2-Methyl-5-(trifluoromethyl)benzonitrile, with the chemical formula C₉H₆F₃N, is a fluorinated aromatic nitrile that has garnered significant attention in the field of pharmaceutical and agrochemical research due to its unique structural and electronic properties. This compound, identified by its CAS number 261952-03-8, represents a class of molecules that exhibit promising biological activities, making it a valuable scaffold for drug discovery and material science applications.

The structural motif of 2-Methyl-5-(trifluoromethyl)benzonitrile consists of a benzene ring substituted with a methyl group at the 2-position and a trifluoromethyl group at the 5-position, with a nitrile group (-CN) attached to the 4-position. The presence of the trifluoromethyl group enhances the lipophilicity and metabolic stability of the molecule, while the nitrile group introduces a polar moiety that can interact with biological targets. These features make it an attractive candidate for further derivatization and exploration in medicinal chemistry.

In recent years, there has been growing interest in fluorinated aromatic compounds due to their ability to modulate pharmacokinetic properties and improve binding affinity to biological targets. The trifluoromethyl group, in particular, is well-documented for its role in enhancing drug efficacy and bioavailability. Studies have shown that incorporation of this moiety can lead to increased metabolic stability, reduced susceptibility to enzymatic degradation, and improved cell membrane penetration. These attributes are particularly valuable in the development of small-molecule drugs where optimizing pharmacokinetic profiles is crucial.

Research into 2-Methyl-5-(trifluoromethyl)benzonitrile has revealed its potential as a precursor in the synthesis of various bioactive molecules. For instance, its benzene core can be further functionalized through cross-coupling reactions, such as Suzuki or Buchwald-Hartwig couplings, to introduce additional substituents that may enhance biological activity. The nitrile group also provides a versatile handle for further chemical modifications, including hydrolysis to carboxylic acids or reduction to amides, which are common pharmacophores in drug molecules.

One of the most compelling aspects of 2-Methyl-5-(trifluoromethyl)benzonitrile is its potential application in the development of novel therapeutic agents. Preliminary studies have suggested that derivatives of this compound may exhibit inhibitory activity against various enzymes and receptors involved in diseases such as cancer, inflammation, and neurodegeneration. The combination of lipophilicity provided by the trifluoromethyl group and the polar interaction facilitated by the nitrile moiety suggests that this scaffold could be effective in targeting specific biological pathways.

The pharmaceutical industry has increasingly recognized the importance of fluorinated compounds in drug development. Fluoroaromatics are known for their ability to improve drug-like properties such as solubility, stability, and binding affinity. The methyl group at the 2-position in 2-Methyl-5-(trifluoromethyl)benzonitrile further contributes to these properties by enhancing molecular rigidity and reducing conformational flexibility. This rigidity can be advantageous in designing molecules that fit tightly into biological target sites, thereby improving therapeutic efficacy.

In addition to pharmaceutical applications, 2-Methyl-5-(trifluoromethyl)benzonitrile has shown promise in agrochemical research. Fluorinated compounds are frequently used in crop protection agents due to their enhanced environmental stability and improved bioactivity against pests and pathogens. The structural features of this compound make it a suitable candidate for developing novel pesticides or herbicides that offer improved performance while minimizing environmental impact.

The synthesis of 2-Methyl-5-(trifluoromethyl)benzonitrile typically involves multi-step organic reactions starting from commercially available precursors. Common synthetic routes include halogenation followed by nucleophilic substitution or metal-catalyzed cross-coupling reactions. The introduction of the trifluoromethyl group can be achieved through electrophilic aromatic substitution or via palladium-catalyzed coupling reactions involving trifluoromethanesulfonate esters or other suitable trifluoromethylation reagents. The final step often involves conversion of an intermediate halogenated derivative to the nitrile using appropriate cyanating agents.

The chemical properties of 2-Methyl-5-(trifluoromethyl)benzonitrile make it a versatile building block for further chemical exploration. Its reactivity allows for diverse functionalization strategies, enabling chemists to tailor its properties for specific applications. For example, palladium-catalyzed coupling reactions can be used to introduce aryl or vinyl groups at various positions on the benzene ring, expanding the library of possible derivatives. Additionally, transition-metal-catalyzed hydrogenation reactions can be employed to reduce double bonds or triple bonds present in more complex derivatives.

In conclusion,2-Methyl-5-(trifluoromethyl)benzonitrile (CAS No: 261952-03-8) is a multifaceted compound with significant potential in pharmaceutical and agrochemical research. Its unique structural features, including the presence of both a methyl group and a trifluoromethyl group along with a nitrile substituent,make it an invaluable scaffold for developing novel bioactive molecules. Ongoing research continues to uncover new applications for this compound, underscoring its importance as a key intermediate in modern chemical synthesis.

• 129604-24-6(Benzonitrile, 3,4-bis(trifluoromethyl)-)
• 261952-06-1(4-Methyl-3-(trifluoromethyl)benzonitrile)
• 25753-25-7(2,6-Bis(trifluoromethyl)benzonitrile)
• 1483-43-8(4-(Trifluoromethyl)isophthalonitrile)
• 871571-28-7(3-Methyl-4-(trifluoromethyl)benzonitrile)
• 51012-27-2(2,5-Bis(trifluoromethyl)benzonitrile)
• 447-60-9(2-(Trifluoromethyl)benzonitrile)
• 177952-38-4(2,4-Bis(trifluoromethyl)benzonitrile)
• 1483-44-9(1,4-Benzenedicarbonitrile,2-(trifluoromethyl)-)
• 261952-05-0(4-Methyl-2-(trifluoromethyl)benzonitrile)